VEGFA and thyroid cancer: In the present communication, we observe that estrogen induced angiogenesis is targeted by DIM by downregulating the bioavailability of proangiogenic factor VEGF as evidenced by reduced angiogenesis of HUVEC by DIM treated thyroid cancer cell conditioned medium.